Alerts in the last 24 hours

No Personalised Alerts!

To see personalised alerts you need to be logged in.

Log In

Perrigo Company PLC Add to portfolio

INX:PRGO, Mar 26, 11:18 UTC

Latest INX:PRGO News

Filter your feed

Apply Filter

Wednesday, March 20


News

Perrigo Appoints Seasoned CPG Veteran Ray Silcock As Chief Financial Officer

PRGO

DUBLIN, March 20, 2019 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO) today announced that Ray Silcock will join the Company as Executive Vice President and Chief Financial Officer, effective March 25, 2019. He has been instrumental in transformations and/or mergers that collectively created billions of dollars in shareholder value at major companies including Diamond Foods Inc., Swift & Co, Cott Corporation (at the time - the world's largest private label soft drink company) and UST Inc. Perrigo President and CEO Murray S. Kessler commented, "I have worked with Ray professionally on and off for over 30 years, including as my CFO at UST Inc. where we built great shareholder value. The Company has based these forward-looking statements on its current expectations, assumptions, estimates and projections. While the Company believes these expectations, assumptions, estimates and projections are reasonable, such forward-looking statements are only predictions and involve known and unknown risks and uncertainties, many of which are beyond the Company's control, including: the timing, amount and cost of any share repurchases; future impairment charges; the success of management transition; customer acceptance of new products; competition from other industry participants, some of whom have greater marketing resources or larger market shares in certain product categories than the Company does; pricing pressures from customers and consumers; resolution of uncertain tax positions, including the Company's appeal of the Notice of Assessment issued by the Irish tax authority ("NoA") and the impact that an adverse result in such proceedings would have on operating results, cash flows, and liquidity; potential third-party claims and litigation, including litigation relating to the Company's restatement of previously-filed financial information and litigation relating to uncertain tax positions, including the NoA; potential impacts of ongoing or future government investigations and regulatory initiatives; the impact of tax reform legislation and healthcare policy; general economic conditions; fluctuations in currency exchange rates and interest rates; the consummation of announced acquisitions or dispositions and the success of such transactions, and the Company's ability to realize the desired benefits thereof; and the Company's ability to execute and achieve the desired benefits of announced cost-reduction efforts and strategic and other initiatives.

Read Full Details

Topics:
  • Business
  • Financial

Monday, March 18


News

Perrigo Announces Tentative FDA Approval For The Generic Version Of Finacea® Foam, 15%

PRGO

DUBLIN, March 18, 2019 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO) a leading global provider of "Quality, Affordable, Self-Care Products™" today announced it has received tentative approval from the U.S. Food and Drug Administration for the generic version of Finacea® Foam (azelaic acid) 15%. Subsequently, LEO Pharma A/S acquired Finacea® Foam (azelaic acid) 15% from Bayer AG and then substituted for Bayer AG as the lead plaintiff in the patent litigation suit concerning the product. Perrigo Executive Vice President and President Rx Pharmaceuticals Sharon Kochan stated, "Our R&D team continues its diligent efforts to secure regulatory approvals for important new products. This tentative approval reflects our continued dedication to developing specialized, extended topical products for the benefit of patients and payors, as well as further illustrates our commitment to advancing our new product pipeline." The Company has based these forward-looking statements on its current expectations, assumptions, estimates and projections. While the Company believes these expectations, assumptions, estimates and projections are reasonable, such forward-looking statements are only predictions and involve known and unknown risks and uncertainties, many of which are beyond the Company's control, including: the timing, amount and cost of any share repurchases; future impairment charges; the success of management transition; customer acceptance of new products; competition from other industry participants, some of whom have greater marketing resources or larger market shares in certain product categories than the Company does; pricing pressures from customers and consumers; resolution of uncertain tax positions, including the Company's appeal of the Notice of Assessment issued by the Irish tax authority ("NoA") and the impact that an adverse result in such proceedings would have on operating results, cash flows, and liquidity; potential third-party claims and litigation, including litigation relating to the Company's restatement of previously-filed financial information and litigation relating to uncertain tax positions, including the NoA; potential impacts of ongoing or future government investigations and regulatory initiatives; the impact of tax reform legislation and healthcare policy; general economic conditions; fluctuations in currency exchange rates and interest rates; the consummation of announced acquisitions or dispositions and the success of such transactions, and the Company's ability to realize the desired benefits thereof; and the Company's ability to execute and achieve the desired benefits of announced cost-reduction efforts and strategic and other initiatives.

Read Full Details

Topics:
  • Business
  • Financial

Sunday, March 17


News

As Perrigo Co Plc Shs (PRGO) Shares Declined, Shareholder Clal Insurance Enterprises Holdings LTD Increased by $15.20 Million Its Stake

PRGO

The ratio improved due to PRGO positioning: 61 sold and 99 reduced. Investors holded 110.26 million in 2018Q3 but now own 111.32 million shares or 0.97% more. State Of Alaska Department Of Revenue holds 0.03% in Perrigo Company plc (NYSE:PRGO) or 39,758 shs. Clal Insurance Enterprises Holdings Ltd has cut its stake in Paypal Hldgs Inc Com and also reduced its holding in Aercap Holdings Nv Shs (NYSE:AER) by 221,128 shares in the quarter, for a total of 1.04 million shares. For more Perrigo Company plc (NYSE:PRGO) news published briefly go to: Globenewswire.com, Globenewswire.com, Seekingalpha.com, Globenewswire.com or Globenewswire.com.

Read Full Details

Topics:
  • Business
  • Financial

Monday, March 11


News

Stock Update for Perrigo Company plc (NYSE:PRGO)

PRGO

The 52-week high is currently $86.51, and the 52-week low is presently $36.5. When the current stock price is trading close to either the 52-week high or 52-week low, investors may pay increased attention to see if there will be a breakthrough that level. To achieve success in the market, investors may take many different paths. Because there are so many different strategies, one investor’s road may end up being quite different than another. Trading the stock market can indeed be exhilarating, but it can also cause lots of strife. Some investors may be able to be much more aggressive when creating the stock portfolio. Others may have a much lower risk threshold and choose to play it a bit safer. Because humans are prone to error, there may be many mistakes made along the way. These estimates hold a lot of weight on Wall Street and the investing community. Sometimes these analyst projections are spot on, and other times they are off. When a company reports actual earnings results, the surprise factor can cause a stock price to fluctuate.

Read Full Details

Topics:
  • Business
  • Financial

Thursday, March 07


News

*Perrigo Co Plc Shs (PRGO) Stake Maintained by Clal Insurance Enterprises Holdings Ltd

PRGO

*Perrigo Co Plc Shs (PRGO) Stake Maintained by Clal Insurance Enterprises Holdings Ltd. Big Money Sentiment increased to 0.81 in 2018 Q4. Acadian Asset Mgmt Limited Liability Corp holds 0.01% of its capital in Perrigo Company plc (NYSE:PRGO) for 31,845 shs. PRGO is touching $46.55 during the last trading session, after decreased 1.59%.Currently Perrigo Company plc is downtrending after 36.89% change in last March 7, 2018. Clal Insurance Enterprises Holdings Ltd has cut its stake in Aercap Holdings Nv Shs (NYSE:AER) and also reduced its holding in Mosaic Co New Com (NYSE:MOS) by 633,000 shares in the quarter, for a total of 1.35M shares. For more Perrigo Company plc (NYSE:PRGO) news announced briefly go to: Globenewswire.com, Globenewswire.com, Globenewswire.com, Globenewswire.com or Globenewswire.com.

Read Full Details

Topics:
  • Business
  • Financial
News

Recent Analysis Shows Veeva, Mobile TeleSystems OJSC, Jacobs Engineering Group, Perrigo Company plc, AstraZeneca, and Primoris Services Market Influences — Renewed Outlook, Key Drivers of Growth

PRGO JEC +2 more PRGO JEC AZN AZN

The new research reports from Fundamental Markets, available for free download at the links above, examine Veeva Systems Inc. (NYSE:VEEV), Mobile TeleSystems OJSC (NYSE:MBT), Jacobs Engineering Group Inc. (NYSE:JEC), Perrigo Company plc (NYSE:PRGO), AstraZeneca PLC (NYSE:AZN), and Primoris Services Corporation (NASDAQ:PRIM) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed March 5th, 2019. To read the full Perrigo Company plc (PRGO) report, download it here: http://Fundamental-Markets.com/register/?so=PRGO. ASTRAZENECA PLC (AZN) REPORT OVERVIEW. AstraZeneca's Recent Financial Performance. For the three months ended September 30th, 2018 vs September 30th, 2017, AstraZeneca reported revenue of $5,340.00MM vs $6,232.00MM (down 14.31%) and analysts estimated basic earnings per share $0.17 vs $0.27 (down 37.04%). For the twelve months ended December 31st, 2018 vs December 31st, 2017, AstraZeneca reported revenue of $22,090.00MM vs $22,465.00MM (down 1.67%) and analysts estimated basic earnings per share $1.70 vs $1.19 (up 43.46%).

Read Full Details

Topics:
  • Business
  • Financial

Tuesday, March 05


News

Mivtachim The Workers Social Insurance Fund LTD Increased Its Stake in Perrigo Co Plc Shs (PRGO)

PRGO

Van Eck Associate Corporation has 0.04% invested in Perrigo Company plc (NYSE:PRGO) for 192,007 shs. The holdings In Perrigo Co Plc Shs (PRGO) was upped held by Mivtachim The Workers Social Insurance Fund Ltd. Now the institutional investor is holding 1.76 million shares, compared to the 1.68M from the previous quarter. For a total of 645,586 shares it reduced its holding in Ormat Technologies Inc (NYSE:ORA) by 109,000 shares in the quarter, and has cut its stake in . For more Perrigo Company plc (NYSE:PRGO) news brought out recently go to: Globenewswire.com, Globenewswire.com, Globenewswire.com, Globenewswire.com or Globenewswire.com. The titles are as follows: “DEADLINE TODAY: UPDATE for YRCW, PRGO and YRIV: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders – GlobeNewswire” brought out on March 04, 2019, “FILING DEADLINE–Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of DNKEY, ARLO, SOGO and PRGO – GlobeNewswire” on February 27, 2019, “CLASS ACTION UPDATE for TDOC, ARLO, PRGO and MAXR: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders – GlobeNewswire” with a publish date: February 11, 2019, “SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Perrigo Company plc (PRGO), Liberty Health Sciences Inc. (LHSIF) and China TechFaith Wireless Communication Technology Limited (CNTF) and Sogou Inc. (SOGO) – GlobeNewswire” and the last “CLASS ACTION UPDATE for PRGO, MKL, ATVI and MU: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders – GlobeNewswire” with publication date: February 20, 2019.

Read Full Details

Topics:
  • Business
  • Financial
News

2025 Analysis on Antidiarrheal Drugs Market Report Forecast By key players Johnson and Johnson, Novartis, GlaxoSmithKline, Proctor and Gamble, Pfizer, Actelion, Perrigo – Industry Chronicles

PRGO PFE +4 more PRGO PFE GSK BMY GILD GSK

Up Market Research offers a latest published report on “Global Antidiarrheal Drugs Market Research Report 2019” delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 101 pages which highly exhibit on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.

Read Full Details

Topics:
  • Business
  • Financial
  • Science

Tuesday, February 26


News

Latest Performance:: The Goodyear Tire & Rubber Company, (NASDAQ: GT), EOG Resources, Inc., (NYSE: EOG), Perrigo Company plc, (NYSE: PRGO), Alta Mesa Resources, Inc., (NASDAQ: AMR)

PRGO

The Consumer Goods stock (The Goodyear Tire & Rubber Company) closed its business at $20.08 by scoring 3.77% (Gain↑) on keep going exchanging session on 25-02-2019 (Monday). In the course of the most recent week, The Goodyear Tire & Rubber Company’s shares returned 6.87% and in the past 30.0 days the figure appeared at -0.59%. Perrigo Company plc, (NYSE: PRGO) make a change of -0.27% (Loss, ↓) with the overall traded volume of 1687806 shares as compare to its average volume of 1.73M shares and finished its business at 48.81. Company’s EPS for the past five years is valued at 0% leading it to an EPS value of 0% for the next five years. As of now, Alta Mesa Resources, Inc. has a P/S, P/E and P/B values of 0.47, 0 and 0.11 respectively.

Read Full Details

Topics:
  • Business
  • Financial
News

EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Perrigo Company plc – PRGO

PRGO

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Perrigo Company plc (NYSE:PRGO) from November 8, 2018 through December 20, 2018, inclusive (the “Class Period”). The lawsuit seeks to recover damages for Perrigo investors under the federal securities laws. The Complaint alleges that on December 20, 2018, Perrigo filed a Form 8-K with the Securities and Exchange Commission disclosing that it had received an audit finding letter from the Irish tax authorities on October 30, 2018 stating “that IP sales transactions… including the sale of Tysabri®, were not part of the trade of Elan Pharma and therefore should have been treated as chargeable gains subject to an effective 33% tax rate, rather than the 12.5% tax rate applicable to trading income.” Although Perrigo had revealed to investors on November 8, 2018 that it had received the audit finding letter, it did not disclose material details. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to https://www.rosenlegal.com/cases-1518.html or to discuss your rights or interests regarding this class action, please contact Phillip Kim, Esq. or Zachary Halper, Esq.

Read Full Details

Topics:
  • Business
  • Financial